Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Viemed Healthcare Expects FY25 Net Revenue Of $254M -$265M, Est $251.50M

Author: Benzinga Newsdesk | March 10, 2025 04:21pm

Adjusted EBITDA for the year ending December 31, 2025 is expected to be in the range of $54 million to $58 million.

Posted In: VMD